Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
ITOS
Shares outstanding
38,305,225 shares
Disclosed Ownership
3,826,692 shares
Ownership
10%
Form type
SCHEDULE 13D/A
Filing time
22 Jul 2025, 16:31:28 UTC
Date of event
18 Jul 2025
Previous filing
12 Jun 2025
Next filing
03 Sep 2025

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 10% ownership in ITeos Therapeutics, Inc. Common Stock, par value $0.001 per share (ITOS) on 18 Jul 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13D/A for ITeos Therapeutics, Inc. Common Stock, par value $0.001 per share (ITOS).
  • Disclosed ownership: 10%.
  • Date of event: 18 Jul 2025.

What Changed

  • Previous schedule filing date: 12 Jun 2025.
  • Current filing was accepted on 22 Jul 2025, 16:31.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 10% 3,826,692 0 3,826,692 /s/ Kevin Tang Manager 0001232621
KEVIN TANG 10% 3,826,692 0 3,826,692 /s/ Kevin Tang Self 0001178579
TANG CAPITAL PARTNERS, LP 6.8% 2,618,219 0 2,618,219 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner 0001191935
TANG CAPITAL PARTNERS INTERNATIONAL, LP 3.2% 1,208,473 0 1,208,473 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner 0002064011
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0002036763
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0002036770
CONCENTRA BIOSCIENCES, LLC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0001970065